Organisation: Novartis

Brussels courts ban rebranding of generic parallel imports

These decisions are the first by national courts to interpret the CJEU’s preliminary ruling in Joined Cases C‑253/20 and C‑254/20.

13 June 2024

Smart enforcement, robust licensing and social media crackdowns: highlights from Brand Strategy Summit Europe 2024

Brand owners and law firm leaders offer their top tips for cost-effective enforcement, long-lasting licensing agreements and combatting social media fraud, at this year’s WTR Live: Brand Strategy Summit Europe. 

15 March 2024

USPTO year in review 2023: exclusive interview with trademark commissioner David Gooder

USPTO Trademark Commissioner David Gooder sits down with WTR to outline key developments and challenges at the agency over the past 12 months.

21 December 2023

Revealed: the world’s most active in-house prosecution teams

WTR data analysis uncovers the companies filing the highest number of trademarks in-house – and those filing the highest number across the globe.

20 December 2023

Good news for Novartis in PASCOE v PASCELMO opposition

The General Court confirmed that there was no likelihood of confusion between Novartis’ mark PASCELMO and the earlier mark PASCOE, both covering Class 5 goods.

27 October 2023

Top trademark filers across ASEAN unveiled

Data analysis reveals the companies with the largest trademark portfolios in the Association of Southeast Asian Nations – and evolving trends among the most active filers.

16 October 2023

Nine tips to protect and enforce your brand: highlights from Brand Strategy Summit USA

Industry leaders share their insight on how to build and maintain a world-class brand at WTR’s high-end New York conference.

02 October 2023

Lamborghini and Novartis prove effectiveness of invalidation and opposition proceedings to combat trademark squatting

In its attempts to crack down on malicious trademark registration, the CNIPA is applying Article 44(1) of the Trademark Law. In many cases, however, it is difficult to prove confusion among the relevant public.

14 September 2023

Europe’s biggest demerger; a portfolio of well-loved brands; fighting threats to consumer health: all in a year’s work at Haleon

Sophie Bodet, vice president – head of intellectual property at Haleon, reveals the pivotal role her team played in Europe’s biggest demerger of the past 20 years – all while managing a portfolio of 33,000 trademarks covering some of healthcare’s best-known brands.

07 August 2023

Revealed: the biggest portfolios in Asia-Pacific

We scrutinise the data to reveal the 50 companies with the largest portfolios in five major jurisdictions.

13 July 2023

Unlock unlimited access to all WTR content